215 related articles for article (PubMed ID: 3341836)
1. High-dose furosemide in the treatment of refractory congestive heart failure.
Gerlag PG; van Meijel JJ
Arch Intern Med; 1988 Feb; 148(2):286-91. PubMed ID: 3341836
[TBL] [Abstract][Full Text] [Related]
2. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
3. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
[TBL] [Abstract][Full Text] [Related]
4. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
[TBL] [Abstract][Full Text] [Related]
5. [Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result].
Marenzi G; Guazzi M; Lauri G; Perego GB; Sganzerla P; Agostoni P
Cardiologia; 1994 Nov; 39(11):763-72. PubMed ID: 7736475
[TBL] [Abstract][Full Text] [Related]
6. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
Grosskopf I; Rabinovitz M; Rosenfeld JB
Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
[TBL] [Abstract][Full Text] [Related]
7. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
8. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.
van der Voort PH; Boerma EC; Koopmans M; Zandberg M; de Ruiter J; Gerritsen RT; Egbers PH; Kingma WP; Kuiper MA
Crit Care Med; 2009 Feb; 37(2):533-8. PubMed ID: 19114909
[TBL] [Abstract][Full Text] [Related]
9. [Metolazone in the treatment of refractory heart insufficiency. Experience of 10 cases].
Kirancumar ; Loureiro PA; Correia JM
Rev Port Cardiol; 1989 Nov; 8(11):775-8. PubMed ID: 2631826
[TBL] [Abstract][Full Text] [Related]
10. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
[TBL] [Abstract][Full Text] [Related]
11. Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.
Zenuk C; Healey J; Donnelly J; Vaillancourt R; Almalki Y; Smith S
Can J Clin Pharmacol; 2003; 10(4):184-8. PubMed ID: 14712323
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure.
Paterna S; Parrinello G; Amato P; Dominguez L; Pinto A; Maniscalchi T; Cardinale A; Licata A; Amato V; Licata G; Di Pasquale P
Adv Ther; 1999; 16(5):219-28. PubMed ID: 10915397
[TBL] [Abstract][Full Text] [Related]
13. Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure.
Vitolo E; Segalini G; Carini L; Castini D; Moreo A; Mazzola C; Segagni S; Villa G; Salvadeo A
Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):327-34. PubMed ID: 3209280
[TBL] [Abstract][Full Text] [Related]
14. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
Dormans TP; Gerlag PG
Eur Heart J; 1996 Dec; 17(12):1867-74. PubMed ID: 8960430
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
[TBL] [Abstract][Full Text] [Related]
16. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
17. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P
J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113
[TBL] [Abstract][Full Text] [Related]
18. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
19. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
20. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
Yasky J; Ledesma GA; Tutera A; Collia LF
Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
